The Enterprise Value as of November 2024 (TTM) for iTeos Therapeutics, Inc. (ITOS) is 76.18M

According to iTeos Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 76.18M. This represents a change of -70.38% compared to the average of 257.14M of the last 4 quarters.

iTeos Therapeutics, Inc. (ITOS) Historical Enterprise Value (quarterly & annually)

How has ITOS Enterprise Value performed in the past?

The mean historical Enterprise Value of iTeos Therapeutics, Inc. over the last ten years is 497.43M. The current 76.18M Enterprise Value has changed 1.43% with respect to the historical average. Over the past ten years (40 quarters), ITOS's Enterprise Value was at its highest in in the March 2021 quarter at 867.80M. The Enterprise Value was at its lowest in in the September 2022 quarter at -30406153.00.

iTeos Therapeutics, Inc. (ITOS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of iTeos Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

iTeos Therapeutics, Inc. (ITOS) Average Enterprise Value

How has ITOS Enterprise Value performed in the past?

The current Enterprise Value of iTeos Therapeutics, Inc. (ITOS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

iTeos Therapeutics, Inc. (ITOS) Enterprise Value vs. Peers

How is ITOS’s Enterprise Value compared to its peers?

iTeos Therapeutics, Inc.’s Enterprise Value is less than Icosavax, Inc. (713.87M), less than Mirati Therapeutics, Inc. (3.91B), less than VectivBio Holding AG (848.58M), less than Annexon, Inc. (642.06M), less than Gracell Biotechnologies Inc. (5.49B), less than Theseus Pharmaceuticals, Inc. (138.26M), less than Monte Rosa Therapeutics, Inc. (481.73M), less than Design Therapeutics, Inc. (251.43M), less than Erasca, Inc. (649.58M), less than Apellis Pharmaceuticals, Inc. (3.52B), less than TScan Therapeutics, Inc. (111.13M), less than Terns Pharmaceuticals, Inc. (494.74M), less than Day One Biopharmaceuticals, Inc. (865.54M), less than Acumen Pharmaceuticals, Inc. (131.19M), less than Amylyx Pharmaceuticals, Inc. (312.13M), less than MoonLake Immunotherapeutics (2.60B), less than Revolution Medicines, Inc. (8.93B), less than Blueprint Medicines Corporation (6.06B), less than Sana Biotechnology, Inc. (773.99M), less than Kymera Therapeutics, Inc. (2.94B),

Build a custom stock screener for iTeos Therapeutics, Inc. (ITOS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like iTeos Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

iTeos Therapeutics, Inc. (ITOS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like iTeos Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.